Rosemont, Ill., March 16, 2022 (GLOBE NEWSWIRE) — A retrospective evaluation of 600 fenestrated-branched endovascular aortic repairs for the treatment of complex aneurysms revealed that fewer than one in five patients experienced an intraoperative adverse event (IAE). Thoraco-abdominal aortic aneurysm repair is among the most complex and serious operations in […]
Other News
Hyloris reports results for the full year 2021
Added 4 additional innovative product candidates Strong growth in H2 leading to total revenues of €3.1 million (€0.2 million in 2020) Significant expansion of commercial footprint of Maxigesic® IV Tranexamic RTU licensing extended beyond U.S. €50 million in cash and cash equivalents to execute ambitious growth strategy LIÈGE, Belgium, March […]
Solstice Supports the American Heart Association’s Broward Heart Walk
Funds raised by Solstice’s Heart Walk team support the lifesaving work of the American Heart Association. PLANTATION, Fla., March 15, 2022 (GLOBE NEWSWIRE) — Solstice sponsored the finish line at the American Heart Association (AHA) Broward Heart Walk on Sunday, March 13. The Heart Walk, held annually at Nova Southeastern […]
CareDx Brings Together Leading Transplant Experts to Share Latest Advancements in the Field of Xenotransplantation
SOUTH SAN FRANCISCO, Calif., March 16, 2022 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that it will hold a virtual “Xenotransplantation Innovation Day” featuring a […]
Vivasure Medical Announces First Patient Treated in U.S. Early Feasibility Study Evaluating PerQseal+
Study is the first in the U.S. to evaluate the company’s fully absorbable, patch-based percutaneous closure device for large-bore vessels in transcatheter aortic valve replacement GALWAY, Ireland–(BUSINESS WIRE)–Vivasure Medical®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced that the first patient was treated in a […]
Cardiawave Announces the Success of Its Clinical Trial to Treat Aortic Stenosis Using VALVOSOFT®, Its Disruptive, Non-Invasive, Ultrasound Treatment
The trial with VALVOSOFT® its disruptive, non-invasive, ultrasound treatment was proven to: be safe and feasible provide a sustained repair of the aortic valve improve quality of life of the 34 patients treated PARIS–(BUSINESS WIRE)–Cardiawave SA, a deeptech medical device company that has developed VALVOSOFT® a revolutionary non-invasive medical device to […]
DiA Imaging Analysis Teams up with Healthcare Technology Company to Expand its AI Offering for Echo-lab Cardiac Exams
DiA’s cardiac ultrasound AI will be implemented into Healthcare Technology Company’s CPACS workflow automating echo labs readflow and improving insights for imaging specialists BEER SHEVA, Israel, March 15, 2022 /PRNewswire/ — DiA Imaging Analysis Ltd, a leading global provider of AI-powered ultrasound analysis software, announced today a multi-year agreement with Change Healthcare, a global […]
Artivion Publishes Inaugural Corporate Responsibility Report
ATLANTA, March 14, 2022 /PRNewswire/ — Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today published its inaugural Corporate Responsibility Report detailing the company’s Environmental, Social, and Governance (ESG) initiatives. Artivion’s 2022 Corporate Responsibility Report details several of the company’s ESG efforts, including: Environmental initiatives to drive sustainability and limit […]
Mineralys Therapeutics Appoints Adam Levy as Chief Financial Officer and Chief Business Officer
PHILADELPHIA, March 15, 2022 /PRNewswire/ — Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company committed to developing best-in-class, novel therapy for the treatment of hypertension, today announced the appointment of Adam Levy as the company’s new Chief Financial Officer (CFO) and Chief Business Officer (CBO). “We are pleased to announce Adam’s appointment and welcome […]
Semler Scientific’s Board of Directors authorizes an up to $20.0 million stock repurchase program
SANTA CLARA, Calif., March 14, 2022 /PRNewswire/ — Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that its board of directors has authorized a $20.0 million stock repurchase program. Semler Scientific may purchase shares on a discretionary basis from time […]



